Literature DB >> 9890967

Interactions of the alpha-spectrin N-terminal region with beta-spectrin. Implications for the spectrin tetramerization reaction.

L Cherry1, N Menhart, L W Fung.   

Abstract

Spectrin of the erythrocyte membrane skeleton is composed of alpha- and beta-spectrin, which associate to form heterodimers and tetramers. It has been suggested that a fractional domain (helix C) in the amino-terminal region of alpha-spectrin (Nalpha region) bundles with another fractional domain in the carboxyl-terminal region of beta-spectrin (Cbeta region) to yield a triple alpha-helical bundle and that this helical bundling is largely responsible for tetramer formation. However, there are certain objections to assigning a preeminent role to this helical bundling in the tetramerization reactions. We prepared several recombinant peptides of alpha-spectrin fragments spanning only the Nalpha region (lacking the dimer nucleation site) and quantitatively studied their interaction with beta-spectrin. We found that a majority of the interactions were localized, as expected, in the Nalpha-helix C region but that there was also some contribution from the nonhomologous region. More importantly, the temperature and ionic strength dependence of this interaction in our model peptides was different from that in intact spectrin. We suggest that, although the regions involving the putative helical bundling in alpha- and beta-spectrin undoubtedly play a significant role in tetramerization, regions distal to the Nalpha-helix C region in spectrin are also involved in tetramer formation. Structural flexibility and lateral interactions may play a role in spectrin tetramerization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890967     DOI: 10.1074/jbc.274.4.2077

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Flexibility of the alpha-spectrin N-terminus by EPR and fluorescence polarization.

Authors:  L Cherry; L W Fung; N Menhart
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

Review 2.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

3.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

Review 4.  The role of βII spectrin in cardiac health and disease.

Authors:  Mohamed H Derbala; Aaron S Guo; Peter J Mohler; Sakima A Smith
Journal:  Life Sci       Date:  2017-11-09       Impact factor: 5.037

5.  Cardiac spectrins: alternative splicing encodes functional diversity.

Authors:  Thomas J Hund; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2010-02-06       Impact factor: 5.000

6.  Intertwined αβ spectrin meeting helical actin protofilament in the erythrocyte membrane skeleton: wrap-around vs. point-attachment.

Authors:  Paul Sche; Carlos Vera; L Amy Sung
Journal:  Ann Biomed Eng       Date:  2011-03-17       Impact factor: 3.934

7.  Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.

Authors:  Omar Niss; Satheesh Chonat; Neha Dagaonkar; Marya O Almansoori; Karol Kerr; Zora R Rogers; Patrick T McGann; Maa-Ohui Quarmyne; Mary Risinger; Kejian Zhang; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2016-07-17       Impact factor: 3.039

8.  Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site.

Authors:  Paola A Bignone; Anthony J Baines
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

9.  Clinical and molecular genetic analysis of a Chinese family with hereditary elliptocytosis caused by a novel mutation in the EPB41 gene.

Authors:  Manxiong Cao; Zhanqin Huang; Huanbing Zhou; Jinghua Lin; Dongqing Zhang
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.